The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
The immune system of children: the key to understanding SARS-CoV-2 susceptibility?
Open accessAbstract
Humanity has repeatedly faced epidemics of known and novel pathogens and the immune system has adapted to survive. Since severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new zoonotic pathogen, there is no pre-existing immunity and the whole of humanity is susceptible to infection and developing COVID-19 disease. Adults can be infected with different outcomes, from asymptomatic, mild, moderate to severe disease, and death. Children can also be infected by SARS-CoV-2, but most paediatric cases with laboratory-confirmed SARS-CoV-2 infection are mild; severe COVID-19 disease in children is rare. Children are more vulnerable to other infections; thus, the important question arises—why are children less susceptible to COVID-19 disease compared with adults? So far, there is no evidence of a lower degree of expression or function of the SARS-CoV-2 receptor (namely ACE2) in children. Thus, studying the innate immune system of children might be the key to understanding protection against or susceptibility to SARS-CoV-2. During the first months of life, maternal antibodies protect the child from the microorganisms that the mother has encountered previously. Although water sanitation and hygiene practices have reduced epidemics and vaccines have been developed to prevent potentially lethal diseases, all microorganisms are new for the child. The frequent infections occurring in the first years of life serve to build the pool of memory T and B cells that will prevent reinfection or development of disease by commonly encountered pathogens. Thus, the paediatric immune system is prepared and fit to react to novelty, a function that might be diminished in adults and ineffective in elderly people aged 70 years or older. Although innate immunity and T cells play a crucial role in the defense against infection, antibodies also play an important role. In the SARS, Ebola, and H1N1 epidemics, convalescent plasma containing antibodies from patients who had recovered from viral infections was used for treatment at the early stage of disease. Human monoclonal antibodies obtained from cloned B cells of a convalescent SARS-Cov-2 might become candidate therapeutics. In most cases, viral load peaks in the first week of infection and patients generate a primary immune response by days 10–14, followed by virus clearance through the action of high-affinity antibodies and T cells. The response of naive B cells to any novel infection or vaccine occurs through the germinal centre reaction and takes 2 weeks. This is a reasonable time for the response to a vaccine, but it is much too long for the response to infection. In the germinal centre, B cells modify their antibodies through the introduction of somatic mutations in the antigen-binding site of the immunoglobulin variable heavy chain genes. Only modified B cells that express high-affinity antibodies are selected to become memory B cells (MBCs) and plasma cells. The immune preparedness of children to any novel pathogens, including, SARS-CoV-2 might be based on several factors. First, in the early phases of infection, natural antibodies play a most important role. Natural antibodies, mostly of IgM isotype and generated independently of previous antigen encounters, have a broad reactivity and a variable affinity. They contain the infection during the 2 weeks necessary for production of high-affinity antibodies and MBCs that will clear the virus and prevent reinfection. High-affinity antibodies are expressed by switched MBCs. In humans, natural antibodies are produced by innate or IgM MBCs, a population of MBCs that is generated independently of the germinal centres and is most abundant in children. From this population of B cells, sorted from the blood of young adults never exposed to avian influenza virus, we have cloned human antibodies able to neutralise antigenically diverse H1, H2, H5, H6, H8, and H9 influenza subtypes. Thus, innate or IgM MBCs can bind many different unknown microorganisms. Second, children have the ability to rapidly produce natural antibodies with broad reactivity that have not yet been selected and shaped by the reaction to common environmental pathogens. Following infection, two types of MBC, CD27 and CD27 MBCs, cooperate. The two populations are related but have distinct molecular signatures and functions. CD27 MBCs express highly mutated VH genes shaped Lancet Child Adolesc Health 2020
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Victora, G. D., & Nussenzweig, M. C. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-075032 · Cited by 1,878
Cited by
Ehrenfeld, M., Tincani, A., Andreoli, L., Cattalini, M., Greenbaum, A., Kanduc, D., Alijotas-Reig, J., Zinserling, V., Semenova, N., Amital, H., et al. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102597 · Cited by 559
Multisystem inflammatory syndrome in children related to COVID-19: a systematic review
Hoste, L., Van Paemel, R., & Haerynck, F. (2021) · European Journal of Pediatrics · doi:10.1007/s00431-021-03993-5 · Cited by 455
Transmission of SARS-CoV-2 in Australian educational settings: a prospective cohort study
Macartney, K., Quinn, H. E., Pillsbury, A. J., Koirala, A., Deng, L., Winkler, N., Katelaris, A. L., O'Sullivan, M. V. N., Dalton, C., Wood, N., et al. (2020) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(20)30251-0 · Cited by 363
Morales, F., Montserrat-de la Paz, S., Leon, M. J., & Rivero-Pino, F. (2023) · Nutrients · doi:10.3390/nu16010001 · Cited by 346
COVID-19: neonatal–perinatal perspectives
On behalf of the Harvard Neonatal-Perinatal Fellowship COVID-19 Working Group, Barrero-Castillero, A., Beam, K. S., Bernardini, L. B., Ramos, E. G. C., Davenport, P. E., Duncan, A. R., Fraiman, Y. S., Frazer, L. C., Healy, H., et al. (2021) · Journal of Perinatology · doi:10.1038/s41372-020-00874-x · Cited by 92
Metadata
- Authors
- Carsetti, R., Quintarelli, C., Quinti, I., Piano Mortari, E., Zumla, A., Ippolito, G., & Locatelli, F.
- Venue
- The Lancet Child & Adolescent Health
- Publisher
- Elsevier BV
- Published
- 2020-06
- Volume
- 4
- Issue
- 6
- Pages
- 414-416
- ISSN
- 2352-4642 (ISSN-L)
- OpenAlex
- W3022379569
- Cited by
- 176
- References
- 1
- FWCI
- 4.13
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The immune system of children: the key to understanding SARS-CoV-2 susceptibility? https://app.cochat.ai/papers/10.1016/s2352-4642(20)30135-8
- The paper
- Carsetti, R., Quintarelli, C., Quinti, I., Piano Mortari, E., Zumla, A., Ippolito, G., & Locatelli, F. (2020). The immune system of children: the key to understanding SARS-CoV-2 susceptibility? The Lancet Child & Adolescent Health. https://doi.org/10.1016/s2352-4642(20)30135-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.